VRC is proud to release its latest industry report. The report provides a concise, insightful update on the Clinical Research Organizations industry including recent transactions, market multiples, company performance and purchase price allocation percentages.

Industry Highlights

• On October 17, 2023, Thermo Fisher Scientific Inc. and Olink Holding AB, a leading provider of next-generation proteomics solutions, announced that their respective boards of directors have approved Thermo Fisher’s proposal to acquire Olink for $26.00 per common share in cash (approximately a 74% premium). The transaction values Olink at approximately $3.1 billion which includes net cash of approximately $143 million.

Past Industry Updates

Clinical Research Organization: June 2023

Clinical Research Organizations: February 2023

Clinical Research Organizations: November 2022